HLA-DPA1 Antikörper (FITC)

Produktnummer ABIN2606269

Produktdetails anti-HLA-DPA1 Antikörper (FITC)

Target: HLA-DPA1 (Major Histocompatibility Complex, Class II, DP alpha 1 (HLA-DPA1))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser HLA-DPA1 Antikörper ist konjugiert mit FITC

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Spezifität: Human HLA-DPA1

Aufreinigung: Caprylic acid and ammonium sulfate precipitation

Immunogen: Recombinant human HLA class II histocompatibility antigen, DP alpha 1 chain protein.

Type of Immunogen: Recombinant protein

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Approved: ELISA, IHC, IHC-P, WB

Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: PBS,  pH 7.4, 0.03 % Proclin 300, 50 % glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid freeze-thaw cycles.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.

Details zu HLA-DPA1

Target: HLA-DPA1 (Major Histocompatibility Complex, Class II, DP alpha 1 (HLA-DPA1))

Andere Bezeichnung: HLA-DPA1 (HLA-DPA1 Produkte)

Synonyme: DP(W3) antikoerper, DP(W4) antikoerper, HLA-DP1A antikoerper, HLADP antikoerper, HLASB antikoerper, PLT1 antikoerper, major histocompatibility complex, class II, DP alpha 1 antikoerper, HLA-DPA1 antikoerper

Hintergrund: Name/Gene ID: HLA-DPA1

Synonyms: HLA-DPA1, DP(W4), DP(W3), HLADP, HLA-SB alpha chain, MHC class II DPA1, HLASB, PLT1, MHC class II antigen, MHC class II DP3-alpha, HLA-DP1A, MHC class II HLA-DPA1 antigen

Gen-ID: 3113

Pathways: T-Zell Rezeptor Signalweg, Cancer Immune Checkpoints